HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antimicrobial soap continuum model could benefit from consumer feedback -- FDA.

This article was originally published in The Rose Sheet

Executive Summary

ANTIMICROBIAL SOAP HEALTH CARE CONTINUUM: CONSUMER FEEDBACK SUGGESTED BY FDA Office of Drug Evaluation V Director Michael Weintraub, MD, at a March 10 "feedback" meeting with FDA, the Cosmetic, Toiletry and Fragrance Association and the Soap and Detergent Association on industry's proposed category of use model for antimicrobial soap products. As the "end users" of antimicrobial products, consumers may have "critiques and constructive suggestions that would be...very valuable" in fine-tuning the continuum, Weintraub said.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005210

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel